Chronic Myeloid Leukaemia: ESMO Clinical Practice Guidelines

Published in 2017 – Ann Oncol (2017) 28 (suppl 4): iv41–iv51
Authors: A. Hochhaus, S. Saussele, G. Rosti, F.-X. Mahon, J. J. W. M. Janssen, H. Hjorth-Hansen, J. Richter and C. Buske

The prevalence of chronic myeloid leukaemia is steadily rising due to the substantial prolongation of survival that has been achieved with targeted therapy. These updated guidelines on chronic myeloid leukaemia provide updated treatment recommendations including the monitoring and management of side effects, as well as a new treatment algorithm for chronic phase chronic myeloid leukaemia patients.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings